日期:
2020 年 — 2026 年
2020
2021
2022
2023
2024
2025
2026
影响因子:

Lenvatinib Plus Pembrolizumab Versus Sunitinib in First-Line Treatment of Advanced Renal Cell Carcinoma: Final Prespecified Overall Survival Analysis of CLEAR, a Phase III Study

仑伐替尼联合帕博利珠单抗对比舒尼替尼在晚期肾细胞癌一线治疗中的应用:III 期临床研究 CLEAR 的最终预设总生存期分析

Robert J Motzer, Camillo Porta, Masatoshi Eto, Thomas Powles, Viktor Grünwald, Thomas E Hutson, Boris Alekseev, Sun Young Rha, Jaime Merchan, Jeffrey C Goh, Aly-Khan A Lalani, Ugo De Giorgi, Bohuslav Melichar, Sung-Hoo Hong, Howard Gurney, María José Méndez-Vidal, Evgeny Kopyltsov, Sergei Tjulandin,

Clinical Presentation, Investigation Findings, and Treatment Outcomes of Spontaneous Intracranial Hypotension Syndrome: A Systematic Review and Meta-analysis

自发性颅内低压综合征的临床表现、检查结果和治疗结果:系统评价和荟萃分析

D'Antona, Linda; Jaime Merchan, Melida Andrea; Vassiliou, Anna; Watkins, Laurence Dale; Davagnanam, Indran; Toma, Ahmed Kassem; Matharu, Manjit Singh

Combining 2-deoxy-D-glucose with fenofibrate leads to tumor cell death mediated by simultaneous induction of energy and ER stress

2-脱氧-D-葡萄糖与非诺贝特结合可导致肿瘤细胞死亡,这是通过同时诱导能量和内质网应激来实现的

Huaping Liu, Metin Kurtoglu, Clara Lucia León-Annicchiarico, Cristina Munoz-Pinedo, Julio Barredo, Guy Leclerc, Jaime Merchan, Xiongfei Liu, Theodore J Lampidis

15-Hydroxyprostaglandin dehydrogenase is a target of hepatocyte nuclear factor 3beta and a tumor suppressor in lung cancer

15-羟基前列腺素脱氢酶是肝细胞核因子 3beta 的靶点,也是肺癌的肿瘤抑制因子

Guosheng Huang, Rosana Eisenberg, Min Yan, Stefano Monti, Earl Lawrence, Pingfu Fu, Jaclyn Walbroehl, Ester Löwenberg, Todd Golub, Jaime Merchan, Daniel G Tenen, Sanford D Markowitz, Balazs Halmos